Intelligent Bio Solutions Forges Manufacturing Alliance With Syrma Johari Medtech

Intelligent Bio Solutions Inc. has formed a new strategic manufacturing partnership with Syrma Johari MedTech Ltd. to support and scale the production of its Intelligent Fingerprinting Drug Screening Reader. The collaboration is also expected to support long-term margin improvement.

The partnership is expected to deliver significant operational and financial benefits for Intelligent Bio Solutions. The company expects to save more than 40% in annual costs, translating to a 20 percentage point gross margin improvement compared with its previous manufacturing arrangement. Additionally, Syrma Johari’s manufacturing capacity is approximately four times Intelligent Bio Solutions’ current capacity, positioning the firm to efficiently support anticipated demand as it scales commercial operations.

The partnership strengthens Intelligent Bio Solutions’ global manufacturing strategy, reducing reliance on a single supplier and building greater resilience into its supply chain. It further broadens capacity, ensures continuity, and creates flexibility as the company prepares for anticipated future demand across multiple regions and planned U.S. market entry this year.

“Partnering with Syrma Johari is a strategically significant milestone for our business,” said Callistus Sequeira, vice president of Global Quality and Operations at Intelligent Bio Solutions. “Its global footprint, manufacturing excellence, and proven track record in regulated medical devices make it an outstanding partner as we scale production of our Drug Screening Reader. This collaboration strengthens our supply chain, supports future growth, and enhances our ability to deliver reliable, high-quality products to customers around the world.”

Syrma Johari has a proven track record in the design, engineering, and production of regulated medical devices. It operates 14 manufacturing locations and four design and innovation centers across India, Europe, and the United States, with a combined plant area of more than 1.1 million square feet.

Syrma Johari’s scale, vertical integration, and export-oriented operating model enable high-quality production while creating efficiencies in sourcing, tooling, testing, and logistics. Its expertise in electronics, mechanical assembly, PCB manufacturing, functional testing, and clean-room processes positions it to produce Intelligent Bio Solutions’ fingerprint drug-screening reader at cost advantages over time, according to the company. As Syrma Johari prepares to open its new medical-grade plastics manufacturing facility in India this month, it is further expanding its capabilities to meet growing global demand and provide international clients with a strategically located, reliable manufacturing alternative in Asia.

Syrma Johari’s extensive regulatory and quality-assurance capabilities further align with Intelligent Bio Solutions’ global expansion plans. It provides end-to-end quality systems, regulatory documentation support, and compliance processes designed to meet the requirements of major jurisdictions, including the United States, Europe, Canada, the United Kingdom, and key Asia-Pacific markets. This depth of experience will support Intelligent Bio Solutions as it continues advancing its regulatory pathways and prepares for increased commercial activity worldwide.

Syrma Johari’s leadership claims the partnership reflects a strong alignment in innovation, quality, and long-term vision. “Partnering with Intelligent Bio Solutions is an exciting opportunity to apply our engineering strength, manufacturing scale, and quality systems to a breakthrough technology with global potential,” said Pankaj Wadke, head of International Sales and Business Development at Syrma Johari MedTech. “At Syrma Johari MedTech, we are committed to enabling solutions that make a meaningful impact, and we look forward to supporting INBS as they expand access to this disruptive, non-invasive drug-screening platform.”

Intelligent Bio Solutions Inc. is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The company is confident its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for recent drug use commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under 10 minutes, this technology would be a valuable tool for employers in safety-critical industries.

Syrma Johari MedTech is a global medical device engineering and manufacturing company with more than 45 years of experience delivering advanced electronics, medical devices, and life-science equipment. Operating 14 manufacturing facilities and multiple R&D centers across India, the United States, and Europe, the company provides end-to-end services spanning design, engineering, prototyping, PCBA, assembly, supply chain, and QARA support. Syrma Johari holds ISO 13485:2016, MDSAP, U.S. Food and Drug Administration, GMP, and TUV SUD certifications and has commercialized more than 245 medical products worldwide.